Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
in response to
by
posted on
Jul 01, 2019 01:55AM
All good feedback and makes sense. Thanks. I guess we’ll see (topline) when we see it and be parsing each word for any hidden clues. I suspect that will be more of a treasure hunt if the endpoint is achieved than if it isn’t. Either way IMO it’s worth waiting until the full data release before making any final judgments.
Look, if the SP does nosedive to 0.25 cents after a bad topline I might be inclined to strengthen my position considerably in case the price rockets back up to (say) a buck should the devil in the detail prove less onerous than what the herd expects. Buy low sell high, or making lemonade out of lemons, still applies nes’t pas?